1. 891PCorrelation between immuno-related adverse events (IRAEs) occurrence and clinical outcome in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: IRAENE trial, an Italian multi-institutional retrospective study. (23rd October 2018) Authors: Vitale, M G; Pipitone, S; Scagliarini, S; Zucali, P A; Galli, L; Rossetti, S; Caserta, C; Iacovelli, R; Masini, C; Ficorella, C; Di Girolamo, S; Buti, S; Benedetti, B; Santoni, M; Porta, C; Bracarda, S; Baldessari, C; Giaquinta, S; Cascinu, S; Sabbatini, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗